nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—ABHD12—optic choroid—refractive error	0.201	0.714	CbGeAlD
Orlistat—ABHD12—eye—refractive error	0.0404	0.144	CbGeAlD
Orlistat—ABHD12—retina—refractive error	0.0401	0.142	CbGeAlD
Orlistat—PLA2G4A—Acyl chain remodelling of PI—PLA2G16—refractive error	0.0383	0.0533	CbGpPWpGaD
Orlistat—FASN—Validated transcriptional targets of deltaNp63 isoforms—AXL—refractive error	0.0377	0.0525	CbGpPWpGaD
Orlistat—PLA2G4A—Acyl chain remodelling of PS—PLA2G16—refractive error	0.0365	0.0508	CbGpPWpGaD
Orlistat—PNLIP—Diseases associated with visual transduction—RDH5—refractive error	0.032	0.0446	CbGpPWpGaD
Orlistat—PLA2G4A—Acyl chain remodelling of PE—PLA2G16—refractive error	0.0287	0.0399	CbGpPWpGaD
Orlistat—PLA2G4A—Acyl chain remodelling of PC—PLA2G16—refractive error	0.0268	0.0373	CbGpPWpGaD
Orlistat—FASN—Defective AMN causes hereditary megaloblastic anemia 1—PCCA—refractive error	0.023	0.0321	CbGpPWpGaD
Orlistat—PLA2G7—Peptide hormone metabolism—PAX6—refractive error	0.0214	0.0297	CbGpPWpGaD
Orlistat—PLA2G4A—p38 MAPK Signaling Pathway—RASGRF1—refractive error	0.0163	0.0227	CbGpPWpGaD
Orlistat—FASN—Integration of energy metabolism—CACNA1D—refractive error	0.0133	0.0185	CbGpPWpGaD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—PCCA—refractive error	0.0129	0.0179	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—ADAMTS18—refractive error	0.0112	0.0156	CbGpPWpGaD
Orlistat—FASN—p73 transcription factor network—PML—refractive error	0.0108	0.0151	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—EBP—refractive error	0.0107	0.0149	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—MPDU1—refractive error	0.00998	0.0139	CbGpPWpGaD
Orlistat—PLA2G4A—Glycerophospholipid biosynthesis—PLA2G16—refractive error	0.0098	0.0136	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—OR2M7—refractive error	0.00801	0.0112	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—OR2M7—refractive error	0.00801	0.0112	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—EBP—refractive error	0.00759	0.0106	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—OR2M7—refractive error	0.00728	0.0101	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—OR2M7—refractive error	0.00728	0.0101	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.00725	0.0101	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.00725	0.0101	CbGpPWpGaD
Orlistat—PLA2G4A—Phospholipid metabolism—PLA2G16—refractive error	0.00684	0.00951	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—VIPR2—refractive error	0.00681	0.00948	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—VIPR2—refractive error	0.00681	0.00948	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—VIPR2—refractive error	0.00619	0.00861	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—VIPR2—refractive error	0.00619	0.00861	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—GREM2—refractive error	0.00567	0.00789	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—GREM2—refractive error	0.00567	0.00789	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—RPS27—refractive error	0.00559	0.00778	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—TUBB3—refractive error	0.00547	0.00761	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.00513	0.00714	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.00513	0.00714	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CHN1—refractive error	0.00482	0.00671	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CHN1—refractive error	0.00482	0.00671	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—EBP—refractive error	0.00478	0.00665	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—GREM2—refractive error	0.0047	0.00654	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—WNT10A—refractive error	0.00469	0.00653	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—WNT10A—refractive error	0.00469	0.00653	CbGpPWpGaD
Orlistat—PNLIP—Disease—DSE—refractive error	0.00433	0.00602	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—OR2M7—refractive error	0.0043	0.00598	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—OR2M7—refractive error	0.0043	0.00598	CbGpPWpGaD
Orlistat—PNLIP—Disease—RDH5—refractive error	0.00407	0.00566	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—PAX6—refractive error	0.00403	0.00561	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CHN1—refractive error	0.004	0.00556	CbGpPWpGaD
Orlistat—PNLIP—Disease—PCCA—refractive error	0.00386	0.00536	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—VIPR2—refractive error	0.00366	0.00509	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—VIPR2—refractive error	0.00366	0.00509	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—DSE—refractive error	0.00362	0.00504	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—OR2M7—refractive error	0.00356	0.00496	CbGpPWpGaD
Orlistat—PNLIP—Disease—IPO5—refractive error	0.00353	0.00491	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—RDH5—refractive error	0.00344	0.00478	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—RDH5—refractive error	0.00344	0.00478	CbGpPWpGaD
Orlistat—FASN—Metabolism—EBP—refractive error	0.00338	0.00471	CbGpPWpGaD
Orlistat—PNLIP—Disease—WNT10A—refractive error	0.00328	0.00456	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—EBP—refractive error	0.00326	0.00453	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—AXL—refractive error	0.00326	0.00453	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—AXL—refractive error	0.00326	0.00453	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PLA2G16—refractive error	0.00323	0.00449	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PCCA—refractive error	0.00323	0.00449	CbGpPWpGaD
Orlistat—PNLIP—Disease—RNF111—refractive error	0.00308	0.00429	CbGpPWpGaD
Orlistat—FASN—Disease—DSE—refractive error	0.00306	0.00426	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—VIPR2—refractive error	0.00303	0.00421	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—VANGL2—refractive error	0.00298	0.00415	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—VANGL2—refractive error	0.00298	0.00415	CbGpPWpGaD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—refractive error	0.00289	0.00403	CbGpPWpGaD
Orlistat—FASN—Disease—RDH5—refractive error	0.00288	0.004	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—RDH5—refractive error	0.00285	0.00396	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—WNT10A—refractive error	0.00277	0.00385	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—WNT10A—refractive error	0.00277	0.00385	CbGpPWpGaD
Orlistat—FASN—Disease—PCCA—refractive error	0.00273	0.0038	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—AXL—refractive error	0.0027	0.00376	CbGpPWpGaD
Orlistat—PNLIP—Disease—LUM—refractive error	0.00267	0.00372	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CER1—refractive error	0.0026	0.00362	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CER1—refractive error	0.0026	0.00362	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—RNF111—refractive error	0.0026	0.00362	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TJP2—refractive error	0.0026	0.00362	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—RNF111—refractive error	0.0026	0.00362	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TJP2—refractive error	0.0026	0.00362	CbGpPWpGaD
Orlistat—FASN—Metabolism—DSE—refractive error	0.00256	0.00357	CbGpPWpGaD
Orlistat—FASN—Disease—IPO5—refractive error	0.00249	0.00347	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—VANGL2—refractive error	0.00247	0.00344	CbGpPWpGaD
Orlistat—FASN—Disease—WNT10A—refractive error	0.00232	0.00323	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—WNT10A—refractive error	0.0023	0.00319	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PML—refractive error	0.00229	0.00319	CbGpPWpGaD
Orlistat—FASN—Metabolism—PLA2G16—refractive error	0.00228	0.00318	CbGpPWpGaD
Orlistat—FASN—Metabolism—PCCA—refractive error	0.00228	0.00318	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—LUM—refractive error	0.00224	0.00311	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.0022	0.00306	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.0022	0.00306	CbGpPWpGaD
Orlistat—FASN—Disease—RNF111—refractive error	0.00218	0.00303	CbGpPWpGaD
Orlistat—PNLIP—Disease—RPS27—refractive error	0.00216	0.00301	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TJP2—refractive error	0.00216	0.003	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CER1—refractive error	0.00216	0.003	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—RNF111—refractive error	0.00216	0.003	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CACNA1D—refractive error	0.00215	0.003	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—COL9A1—refractive error	0.00197	0.00275	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—COL9A1—refractive error	0.00197	0.00275	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CYP26A1—refractive error	0.0019	0.00265	CbGpPWpGaD
Orlistat—FASN—Disease—LUM—refractive error	0.00189	0.00263	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—BUB1B—refractive error	0.00188	0.00262	CbGpPWpGaD
Orlistat—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—refractive error	0.00184	0.00256	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—OR2M7—refractive error	0.00183	0.00255	CbGpPWpGaD
Orlistat—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—refractive error	0.00181	0.00252	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—COL9A1—refractive error	0.00164	0.00228	CbGpPWpGaD
Orlistat—FASN—Metabolism—LUM—refractive error	0.00158	0.0022	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—VIPR2—refractive error	0.00156	0.00217	CbGpPWpGaD
Orlistat—FASN—Disease—RPS27—refractive error	0.00153	0.00213	CbGpPWpGaD
Orlistat—FASN—Metabolism—CACNA1D—refractive error	0.00152	0.00212	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—refractive error	0.00149	0.00207	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—EBP—refractive error	0.00145	0.00202	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GREM2—refractive error	0.00143	0.00199	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.00137	0.0019	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—BMP2—refractive error	0.00135	0.00188	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—BMP2—refractive error	0.00135	0.00188	CbGpPWpGaD
Orlistat—FASN—Metabolism—CYP26A1—refractive error	0.00135	0.00187	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CHN1—refractive error	0.00121	0.00169	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—WNT10A—refractive error	0.00118	0.00164	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—BMP2—refractive error	0.00112	0.00156	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—DSE—refractive error	0.0011	0.00153	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—OR2M7—refractive error	0.00108	0.0015	CbGpPWpGaD
Orlistat—PNLIP—Disease—PDGFRA—refractive error	0.000999	0.00139	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—PTEN—refractive error	0.000985	0.00137	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PLA2G16—refractive error	0.00098	0.00136	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PCCA—refractive error	0.00098	0.00136	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000965	0.00134	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—VIPR2—refractive error	0.00092	0.00128	CbGpPWpGaD
Orlistat—PLA2G4A—Phospholipid metabolism—PTEN—refractive error	0.00091	0.00127	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RDH5—refractive error	0.000865	0.0012	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PDGFRA—refractive error	0.000844	0.00117	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PDGFRA—refractive error	0.000844	0.00117	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AXL—refractive error	0.00082	0.00114	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—CYP26A1—refractive error	0.000791	0.0011	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—CYP26A1—refractive error	0.00078	0.00109	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—VANGL2—refractive error	0.00075	0.00104	CbGpPWpGaD
Orlistat—FASN—Disease—PDGFRA—refractive error	0.000707	0.000984	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.000701	0.000976	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PDGFRA—refractive error	0.0007	0.000974	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—WNT10A—refractive error	0.000697	0.00097	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000682	0.00095	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—LUM—refractive error	0.000679	0.000945	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TJP2—refractive error	0.000655	0.000912	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CER1—refractive error	0.000655	0.000912	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RNF111—refractive error	0.000655	0.000912	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CACNA1D—refractive error	0.000654	0.00091	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CYP26A1—refractive error	0.000578	0.000804	CbGpPWpGaD
Orlistat—PNLIP—Disease—PTEN—refractive error	0.000513	0.000714	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—COL9A1—refractive error	0.000497	0.000691	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PTEN—refractive error	0.000433	0.000603	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PTEN—refractive error	0.000433	0.000603	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTEN—refractive error	0.00043	0.000598	CbGpPWpGaD
Orlistat—FASN—Disease—PTEN—refractive error	0.000363	0.000505	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PTEN—refractive error	0.000359	0.0005	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—BMP2—refractive error	0.00034	0.000474	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—EBP—refractive error	0.00034	0.000473	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTEN—refractive error	0.000304	0.000423	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000293	0.000407	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DSE—refractive error	0.000258	0.000358	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLA2G16—refractive error	0.00023	0.000319	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PCCA—refractive error	0.00023	0.000319	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PDGFRA—refractive error	0.000212	0.000296	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—LUM—refractive error	0.000159	0.000221	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CACNA1D—refractive error	0.000153	0.000213	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP26A1—refractive error	0.000135	0.000188	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTEN—refractive error	0.00013	0.000181	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PTEN—refractive error	0.000109	0.000152	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTEN—refractive error	3.05e-05	4.25e-05	CbGpPWpGaD
